reason report
bottom line increas convict
solid rais increas estim pt
beat across board volum price growth opex
ebitda guidanc increas mm mean yoy
growth nice high end normal growth guidanc
revenu guidanc also growth yoy see
best breed publicli trade hospit view busi
model pois drive acceler growth next year
market share gain tax reform enabl increas capit
spend level play field not-for-profit
servic line improv price growth remain elev
optim higher acuiti offer payor mix hospit
inpati lesser extent outpati set particularli hca
capac util emerg depart ed volum
see acceler convers inpati admiss invest
ambulatori access point current
oper margin expans given fix cost leverag integr
acquir asset addit robust busi model solid
execut aid secular local market macroeconom
tailwind tx fl diminish unemploy popul
migrat acceler commerci volum growth
medicar advantag offer volum growth demograph age
babi boomer bs solid debt ebitda greater
cap ex plan annual dividend yield
forese hospit market concentr health
system share shift top leader
revenu ebitda go mm respect
revenu ebitda acceler mm
pt move contempl ev ebitda
estim
solid revenu ebitda report net revenu
compar consensu adjust ebitda
mm vs consensu mm ep beat consensu
includ gain facil sale tax
benefit due tax cut job act exhibit
volum larg solid across metric ed declin
less profit segment aid secular local
market macroeconom tailwind tx fl market
unemploy nation averag view larg
small employ offer richer health benefit due economi
surgeri trend solid ss inpati surgeri
outpati surgeri ss birth posit
second consecut quarter highest year exhibit
compani inform leerink partner llc research
revenu million bad debt ep present ex one-tim item
ev/ebitda
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth compound-annual-growth-rate
pleas refer page import disclosur price chart analyst certif
price growth remain elev optim higher
acuiti offer payor mix hospit inpati
lesser extent outpati set particularli hca
capac util ed volum see acceler convers
inpati admiss note volum shift
outpati ambulatori hospit inpati acuiti increas
ss case mix optim mix
opex strong across board expect margin
expand recent acquisit integr ss swb
bp yoy labor cost remain stabl ss suppli opex
rais ebitda guidanc yoy growth
midpoint rais guidanc midpoint mm
mm vs consensu mm report revenu
ep guidanc also rais yoy growth
rais estim includ pend
could add addit upsid revenu ebitda
go mm revenu
ebitda acceler mm
respect estim includ pend deal
close includ mission health estim mm
solid capit deploy opportun tax reform lead
multipl expans opportun capit expenditur
mm includ acquisit track
guidanc greater could lead
multipl expans larg opportun also repurchas
mm share dividend yield net debt
ebitda exhibit
rais pt pt contempl ev ebitda
estim exhibit
increas convict solid rais increas
estim pt
beat across board volum price growth opex ebitda guidanc
increas mm mean yoy growth nice high end
normal growth guidanc revenu guidanc also growth yoy
see best breed publicli trade hospit view busi model pois
drive acceler growth next year market share gain tax reform
enabl increas capit spend level play field not-for-profit
servic line improv price growth remain elev optim higher acuiti
offer payor mix hospit inpati lesser extent outpati set
particularli hca capac util ed volum see acceler convers
inpati admiss invest ambulatori access point current
oper margin expans given fix cost leverag integr acquir
addit robust busi model solid execut aid secular
local market macroeconom tailwind tx fl diminish unemploy
popul migrat acceler commerci volum growth medicar advantag
offer volum growth demograph age babi boomer bs solid debt
ebitda greater cap ex plan annual dividend yield
forese hospit market concentr health system share
shift top leader
revenu ebitda go mm respect revenu
ebitda acceler mm pt contempl ev ebitda
estim
solid revenu ebitda report net revenu compar
consensu adjust ebitda mm vs consensu mm ep
beat consensu includ gain facil sale tax
benefit due tax cut job act
volum larg solid across metric ed declin less profit segment
aid secular local market macroeconom tailwind tx fl
market unemploy nation averag view larg small
employ offer richer health benefit due economi surgeri trend solid
quarter ss inpati surgeri outpati surgeri ss birth
posit second consecut quarter highest year
holdingsleerinkconsensusqoqyoynet ebitda bpsd incom net facilityrev/adj admiss bpsadmiss bpsadj admiss bpsss inpati surgeri bpsss outpati surgeri bpser visit bpsexpensessalaries/net bpssupplies/net bpsother expenses/net bpsreport mm except per sharereport estimatesfactset consensu healthcar inc
inpati surgeri surgic admiss total admiss quarter
gener consist prior year surgic volum continu strong cardiovascular vascular
orthoped servic line eight divis growth inpati surgeri outpati surgeri show
strong growth also hospital-bas surgeri freestand ambulatori surgeri center
divis growth outpati surgeri
outpati surgeri inpati surgeri inpati surgeri continu perform pretti good
level forgot exactli mani quarter row inpati growth activ surgic side
realli pleas outpati surgic growth quarter think function
physician recruit ambulatori surgeri center develop choic initi
realli work deliv great experi patient effici well-equip
experi surgeon
price growth remain elev optim higher acuiti offer payor mix
hospit inpati lesser extent outpati set particularli hca
capac util ed volum see acceler convers inpati
admiss note volum shift outpati ambulatori hospit
inpati acuiti increas ss case mix optim mix
payor mix point commerci volum yoy net exchang
compani report leerink partner llc estim note ss commerci adjust admiss exclud impact exchang
unemploy rate fell june lowest rate think year market
unemploy rate lower like nashvil exampl think unemploy rate
importantli tighter labor market survey indic busi offer
gener benefit result importantli us employer-sponsor health insur
see growth larg employ survey indic even smaller
employ employ busi worker offer greater share
employe year offer health insur macro trend think play
well us quot nation statist market perform even better
nation averag think macro favor indic us well
particularli pleas see same-facil manag care exchang adjust admiss increas
second quarter highest growth rate sinc first quarter
peopl employ peopl cover employer-sponsor insur
could see elect activ seen growth birth rate birth volum
obvious elect type case want call part composit well
opex strong across board expect margin expand recent
acquisit integr ss swb bp yoy labor cost remain stabl ss
suppli opex declin bp
rais ebitda guidanc yoy growth midpoint rais
guidanc midpoint mm mm vs consensu mm
report revenu ep guidanc also rais yoy growth respect
rais estim includ pend could add
addit upsid revenu ebitda go mm
revenu ebitda acceler mm
respect estim includ pend deal close includ
mission health estim mm ebitda
consensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkrevenu expense/net opex/net rev/ per adj admiss adj admin inc
compani report leerink partner llc research estim note mm
driver adjust ss top line growth normal baselin mm bp improvementintern uk acquisit savannah ga facil rampok leerink ebitda northwest medic centerhouston houston areacypress fairbank medic center hospit houston houston areapark plaza hospitalhouston houston areatombal region medic centertombal houston areasouth texa region centerjourdanton san antonio areaweatherford region medic centerweatherford dalla ft worth areahighland region medic centersebr mile west ft piercesatilla region medic centerwaycross jacksonvil area facilitiesmemori hospit savannah level picu servic level trauma servic areamiss mission acquisit march medic mission acquisit march ridg region hospitalspruc mission acquisit march mission acquisit march mission acquisit march region hospitalbrevardnapend mission acquisit march inc
solid capit deploy opportun tax reform lead multipl expans
 opportun capit expenditur mm includ acquisit
track guidanc greater could lead multipl
expans larg opportun also repurchas mm share
dividend yield net debt ebitda
growth capital-expenditure
rais pt pt contempl ev ebitda estim
pt contempl ev/ebitda ebitda view
factset compani report leerink partner llc research estim note mm except per share
trade consensu ev/ebitda
factset compani report leerink partner llc research estim note mm except per share
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
base rate outperform price target base
ev/ebitda ebitda view
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut govern commerci payer reimburs
pressur shift outpati ambulatori set
price target base pro forma ebitda leverag post transact
debt repay
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
delay time sale hospit asset initi improv physician
product expens reduct
exposur larg earn swing result high leverag
variou on-going legal proceed may result cash outflow
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
lpnt market perform price target base ev/ebitda
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut government commerci payer reimburs
margin expans headwind class
lack
rate outperform price target base combin enterpris
valu ebitda multipl valuat base forward forecast contempl underli
fundament implic sum-of-the-part valuat rang
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut government commerci payer reimburs
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
outperform price target base ev/ebitda
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
acut care segment highli concentr la vega texa
cut govern commerci payer reimburs
declin receiv collect rate
pay mix pressur behavior segment
incom statement mm except provis doubt net expensessalari oper total oper depreci incom ebit net interest pbt incom tax incom yoy incom attribut non-controlling net incom attribut net incom attribut share dilut yoy dilut yoy growth growth expense/net opex/net debt/gross inc
